Back to search

Article

The Expression and Prognostic Value of CCL19 in Breast Cancer

2022-06-27

Abstract excerpt

<title>Abstract</title> <p>Background Breast cancer is the leading cause of cancer related death in women worldwide. Early diagnosis is the most effective way to reduce breast cancer mortality. Immune and tumor processes are closely related. This study aims to explore the mechanism of immune and potential biomarkers of breast cancer through bioinformatics. Objective First, differentially expressed genes (DEGs)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1933d62-3bd5-5034-9caf-bb8fd194a444
DOI
10.21203/rs.3.rs-1765674/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Expression and Prognostic Value of CCL19 in Breast CancerDOI 10.21203/rs.3.rs-1765674/v1
CCL19 has potential to be a prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA databaseSemantic proximity
Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironmentSemantic proximity
Genetic association of CCL18 and EGF genes elevate the risk of breast cancerSemantic proximity
Comprehensive Analysis of CCL21 in Human Tumors:A Potential Therapeutic Target Associated with Immune InfiltrationSemantic proximity
Low CCL19 Expression Is Associated With Adverse Clinical Outcomes For Patients With Advanced Stage Follicular LymphomaSemantic proximity
CXCL2 as a Prognostic Marker in Breast Cancer is Associated with Immune Infiltration and Regulated by miR-215Semantic proximity
Identification of an Exosome-Related Signature Associated with Prognosis and Immune Infiltration in Breast CancerSemantic proximity
Low CCL19 Expression is Associated With Adverse Clinical Outcomes For Follicular Lymphoma Patients Treated With ChemoimmunotherapySemantic proximity
CCL19 Suppresses Pancreatic Cancer Progression via Immune Microenvironment Remodeling: Bioinformatics and Functional InsightsSemantic proximity
Comprehensive Analysis of Innate Immunophenotyping Based on Immune Score Predicting Immune Alterations and Prognosis in Breast Cancer Patients.Semantic proximity
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancerSemantic proximity
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.